Display options
Cite
Ghemigian A, Carsote M, Sandru F, et al. Neuroendocrine neoplasia and bone (Review). Exp Ther Med. 2021;22(5):1219doi: 10.3892/etm.2021.10653.
Ghemigian, A., Carsote, M., Sandru, F., Petca, R. C., Oproiu, A. M., Petca, A., & Valea, A. (2021). Neuroendocrine neoplasia and bone (Review). Experimental and therapeutic medicine, 22(5), 1219. https://doi.org/10.3892/etm.2021.10653
Ghemigian, Adina, et al. "Neuroendocrine neoplasia and bone (Review)." Experimental and therapeutic medicine vol. 22,5 (2021): 1219. doi: https://doi.org/10.3892/etm.2021.10653
Ghemigian A, Carsote M, Sandru F, Petca RC, Oproiu AM, Petca A, Valea A. Neuroendocrine neoplasia and bone (Review). Exp Ther Med. 2021 Nov;22(5):1219. doi: 10.3892/etm.2021.10653. Epub 2021 Aug 26. PMID: 34584564; PMCID: PMC8422397.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2021 Nov;22(5):1219. doi: 10.3892/etm.2021.10653. Epub 2021 Aug 26.

Neuroendocrine neoplasia and bone (Review).

Experimental and therapeutic medicine

Adina Ghemigian, Mara Carsote, Florica Sandru, Razvan-Cosmin Petca, Ana-Maria Oproiu, Aida Petca, Ana Valea

Affiliations

  1. Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  2. Department of Endocrinology, 'C. I. Parhon' National Institute of Endocrinology, 011863 Bucharest, Romania.
  3. Department of Dermatology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  4. Department of Dermatology, 'Elias' Emergency University Hospital, 011461 Bucharest, Romania.
  5. Department of Urology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  6. Department of Urology, 'Prof. Dr. Theodor Burghele' Clinical Hospital, 061344 Bucharest, Romania.
  7. Department of Plastic and Reconstructive Surgery, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  8. Department of Plastic and Reconstructive Surgery, University Emergency Hospital, 050098 Bucharest, Romania.
  9. Department of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  10. Department of Obstetrics and Gynecology, University Emergency Hospital, 050098 Bucharest, Romania.
  11. Department of Endocrinology, 'I. Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  12. Department of Endocrinology, Clinical County Hospital, 400000 Cluj-Napoca, Romania.

PMID: 34584564 PMCID: PMC8422397 DOI: 10.3892/etm.2021.10653

Abstract

This is a narrative review focusing on neuroendocrine neoplasia (NEN) and bone status, in terms of metastases and osteoporosis/fractures. One fifth of NEN have skeletal dissemination, this affinity being regulated by intrinsic tumor factors such as the C-X-C chemokine receptor 4 (CXCR4). Bone colonization impairs the patient quality of life, representing a surrogate of reduced survival. Patients with NEN without bone metastases may exhibit low bone mineral density, perhaps carcinoid-related osteoporosis, yet not a standardized cause of osteoporosis. Case-finding strategies to address bone health in NEN with a good prognosis are lacking. Contributors to fractures in NEN subjects may include: menopausal status and advanced age, different drugs, induced hypogonadism, malnutrition, malabsorption (due to intestinal resection, carcinoid syndrome), hypovitaminosis D, impaired glucose profile (due to excessive hormones such as glucagon, somatostatinoma or use of somatostatin analogues), various corticoid regimes, and high risk of fall due to sarcopenia. Pheocromocytoma/paraganglioma involve bone through malignant forms (bone is an elective site) and potential secondary osteoporosis due to excessive hormonal content and increased sympathetic activity which is a key player of bone microarchitecture/quality as reflected by low Trabecular Bone Score. Glucocorticoid osteoporosis is related to NEN-associated ectopic Cushing syndrome. Currently, there are a lack of studies to emphasis that excessive gut-derivate serotonin in NENs with carcinoid syndrome is a specific activator of bone loss thus a contributor to carcinoid-related osteoporosis.

Copyright © 2020, Spandidos Publications.

Keywords: bone; carcinoid; dual-energy X-ray absorptiometry; ectopic Cushing syndrome; fractures; neuroendocrine neoplasia; osteoporosis; pheocromocytoma; serotonin

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. Arch Med Res. 2020 Nov;51(8):765-776 - PubMed
  2. Curr Treat Options Oncol. 2020 Aug 29;21(11):85 - PubMed
  3. Pol Arch Med Wewn. 2014;124(11):635-6 - PubMed
  4. Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):e131-e134 - PubMed
  5. Exp Ther Med. 2020 Sep;20(3):2489-2492 - PubMed
  6. Oncotarget. 2018 Apr 10;9(27):19245-19254 - PubMed
  7. Ann Diagn Pathol. 2017 Aug;29:11-16 - PubMed
  8. J Physiol Pharmacol. 2015 Dec;66(6):779-91 - PubMed
  9. J Med Life. 2015;8 Spec Issue:82-6 - PubMed
  10. Prz Gastroenterol. 2020;15(3):207-214 - PubMed
  11. J Clin Med. 2020 Aug 12;9(8): - PubMed
  12. BMC Cancer. 2016 Jan 22;16:36 - PubMed
  13. Bratisl Lek Listy. 2017;118(9):529-534 - PubMed
  14. Endocr Relat Cancer. 2015 Jun;23(6):R229-47 - PubMed
  15. Eur J Endocrinol. 2011 Sep;165(3):383-92 - PubMed
  16. Osteoporos Int. 2017 May;28(5):1507-1529 - PubMed
  17. Cancer Treat Rev. 2016 Mar;44:26-41 - PubMed
  18. BMJ Case Rep. 2019 Aug 21;12(8): - PubMed
  19. Nutrients. 2020 Apr 08;12(4): - PubMed
  20. J Womens Health (Larchmt). 2018 Sep;27(9):1093-1096 - PubMed
  21. Singapore Med J. 2009 Apr;50(4):e147-50 - PubMed
  22. J Korean Med Sci. 2020 Nov 30;35(46):e403 - PubMed
  23. Endocrinol Metab Clin North Am. 2018 Jun;47(2):409-425 - PubMed
  24. Exp Gerontol. 2020 Jan;129:110778 - PubMed
  25. World J Gastroenterol. 2019 Mar 14;25(10):1171-1184 - PubMed
  26. Endocr Connect. 2015 Mar;4(1):9-17 - PubMed
  27. Arch Pathol Lab Med. 2021 Jun 1;145(6):664-677 - PubMed
  28. Eur J Cancer. 2019 Nov;121:7-18 - PubMed
  29. J Endocrinol Invest. 2020 Oct;43(10):1429-1445 - PubMed
  30. Farm Hosp. 2020 Nov 14;45(1):41-44 - PubMed
  31. Kaohsiung J Med Sci. 2012 Jun;28(6):341-4 - PubMed
  32. Int J Cancer. 2016 Dec 15;139(12):2679-2686 - PubMed
  33. Clin Nucl Med. 2017 Oct;42(10):773-775 - PubMed
  34. J Gen Intern Med. 2008 Jun;23(6):875-8 - PubMed
  35. Indian J Surg Oncol. 2020 Sep;11(3):433-437 - PubMed
  36. Eur J Med Genet. 2020 Apr;63(4):103815 - PubMed
  37. Int J Geriatr Psychiatry. 2018 Dec;33(12):1688-1708 - PubMed
  38. Radiol Clin North Am. 2020 Nov;58(6):1147-1159 - PubMed
  39. Endocrine. 2019 Jun;64(3):690-701 - PubMed
  40. Melanoma Res. 2018 Dec;28(6):641-644 - PubMed
  41. Bone. 2018 Nov;116:1-7 - PubMed
  42. Eur J Endocrinol. 2020 Apr;182(4):R29-R58 - PubMed
  43. Am J Transl Res. 2020 Jan 15;12(1):118-129 - PubMed
  44. Physiol Res. 2019 Nov 30;68(Suppl 2):S149-S156 - PubMed
  45. Front Endocrinol (Lausanne). 2020 Nov 18;11:591501 - PubMed
  46. Histopathology. 2008 Jan;52(2):119-29 - PubMed
  47. Front Endocrinol (Lausanne). 2019 Aug 30;10:580 - PubMed
  48. Prz Menopauzalny. 2017 Jun;16(2):70-73 - PubMed
  49. Spine J. 2019 Mar;19(3):411-417 - PubMed
  50. Endocrine. 2018 Mar;59(3):547-554 - PubMed
  51. J Clin Endocrinol Metab. 2013 Apr;98(4):1492-7 - PubMed
  52. Clin Nucl Med. 2019 Mar;44(3):257-258 - PubMed
  53. Curr Osteoporos Rep. 2020 Feb;18(1):38-46 - PubMed
  54. Virchows Arch. 2018 Mar;472(3):341-349 - PubMed
  55. Curr Opin Endocrinol Diabetes Obes. 2020 Jun;27(3):146-154 - PubMed
  56. Biochimie. 2019 Jun;161:56-64 - PubMed
  57. J Bone Miner Res. 2014 Sep;29(9):1926-8 - PubMed
  58. Histopathology. 2021 Jan;78(1):162-170 - PubMed
  59. Hormones (Athens). 2016 Oct;15(4):540-547 - PubMed
  60. Rom J Morphol Embryol. 2011;52(1):187-92 - PubMed
  61. Clin Endocrinol (Oxf). 2014 Feb;80(2):246-52 - PubMed
  62. Pancreas. 2020 Oct;49(9):1123-1130 - PubMed
  63. World J Nucl Med. 2017 Jan-Mar;16(1):62-67 - PubMed
  64. Exp Ther Med. 2020 Oct;20(4):3389-3393 - PubMed
  65. World J Surg Oncol. 2013 Jun 05;11:128 - PubMed
  66. Exp Ther Med. 2020 Oct;20(4):3383-3388 - PubMed
  67. Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S8 - PubMed
  68. Eur Radiol. 2018 Sep;28(9):3943-3952 - PubMed
  69. J Endocrinol Invest. 2019 Oct;42(10):1149-1164 - PubMed
  70. Cancers (Basel). 2019 Sep 08;11(9): - PubMed
  71. Neuroendocrinology. 2021;111(3):207-216 - PubMed
  72. Bone. 2020 Apr;133:115221 - PubMed
  73. Semin Oncol. 2018 Aug;45(4):249-258 - PubMed
  74. Br Med Bull. 2020 May 15;133(1):105-117 - PubMed
  75. Eur Radiol. 2021 Jun;31(6):4166-4174 - PubMed
  76. Clin Endocrinol (Oxf). 2019 Nov;91(5):633-638 - PubMed
  77. Clin Rheumatol. 2021 Feb;40(2):775-782 - PubMed
  78. Radiol Clin North Am. 2020 Nov;58(6):1161-1171 - PubMed
  79. Osteoporos Int. 2020 Aug;31(8):1499-1506 - PubMed
  80. Clin Nucl Med. 2017 Jun;42(6):463-464 - PubMed
  81. Bone Res. 2013 Sep 25;1(3):260-6 - PubMed
  82. Br J Neurosurg. 2019 Dec;33(6):620-623 - PubMed
  83. Sisli Etfal Hastan Tip Bul. 2020 Jun 03;54(2):159-168 - PubMed
  84. BMC Endocr Disord. 2020 Apr 3;20(1):44 - PubMed
  85. Cancer Med. 2019 Dec;8(17):7288-7298 - PubMed
  86. Semin Musculoskelet Radiol. 2014 Apr;18(2):149-65 - PubMed
  87. Oncol Lett. 2012 May;3(5):1105-1108 - PubMed
  88. Neuroendocrinology. 2020;110(7-8):688-696 - PubMed
  89. Curr Oncol Rep. 2017 Oct 28;19(12):83 - PubMed
  90. Endocrinol Metab Clin North Am. 2018 Jun;47(2):299-311 - PubMed
  91. J Med Life. 2020 Oct-Dec;13(4):449-453 - PubMed
  92. Cancer Metastasis Rev. 2013 Jun;32(1-2):189-200 - PubMed
  93. Curr Opin Endocrinol Diabetes Obes. 2019 Jun;26(3):125-132 - PubMed
  94. Recent Pat Endocr Metab Immune Drug Discov. 2015;9(2):79-89 - PubMed
  95. Ann Hepatobiliary Pancreat Surg. 2017 Feb;21(1):61-65 - PubMed
  96. Medicine (Baltimore). 2019 Nov;98(44):e17773 - PubMed
  97. Sci Rep. 2020 Jan 29;10(1):1456 - PubMed
  98. Rom J Morphol Embryol. 2013;54(1):201-3 - PubMed
  99. Br J Cancer. 2019 Feb;120(3):294-300 - PubMed
  100. Clin Endocrinol (Oxf). 2018 Aug;89(2):148-154 - PubMed
  101. J Clin Endocrinol Metab. 2012 Jul;97(7):2223-30 - PubMed
  102. Bone. 2021 Jan;142:115607 - PubMed
  103. J Ayub Med Coll Abbottabad. 2016 Jul-Sep;28(3):617-619 - PubMed
  104. BMC Endocr Disord. 2017 Jul 13;17(1):39 - PubMed
  105. Osteoporos Int. 2020 Nov;31(11):2151-2160 - PubMed
  106. Oncotarget. 2017 Apr 4;8(14):22534-22549 - PubMed

Publication Types